Loading…
Reported covered position: Senior Advisor to the Assistant Secretary of Public Affairs (HHS)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
To amend the Child Abuse Prevention and Treatment Act with respect to infants born with and identified as being affected by substance use or withdrawal symptoms, Neonatal Abstinence Syndrome, or Fetal Alcohol Spectrum Disorder, and for other purposes.
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to reimbursement of Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2025 · first_quarter · Q1
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to reimbursement of Part B drugs. Issues related to virtual supervision of infusion drugs. H.R. 879 Medicare Patient Access and Practice Stabilization Act Issues related to physician reimbursement to complex drug administration. Issues related to appropriate reimbursement for administration of Part B drugs.
Advocating for access to and reimbursement for biosimilars. Issues related to patient access to infusion products for asthma and allergies.
Source: Senate LDA
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Protecting Patient Access to Cancer and Complex Therapies Act of 2023
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Protecting Patient Access to Cancer and Complex Therapies Act of 2023
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Invest in American Railroads Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
To amend the Occupational Safety and Health Act of 1970 to prohibit emergency temporary standards with respect to vaccines, and for other purposes.
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
To amend the Occupational Safety and Health Act of 1970 to prohibit emergency temporary standards with respect to vaccines, and for other purposes.
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Access to Alzheimer's Disease therapies.
New Parents Act of 2021
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
New Parents Act of 2021
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Access to Alzheimer's Disease therapies.
Strengthening Medicare for Patients and Providers Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Strengthening Medicare for Patients and Providers Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Strengthening Medicare for Patients and Providers Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Pharmacy Benefits Manager Accountability Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Pharmacy Benefits Manager Accountability Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
Pharmacy Benefits Manager Accountability Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Transparent PRICE Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Transparent PRICE Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
Transparent PRICE Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department.
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department.
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Providers and Payers COMPETE Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Providers and Payers COMPETE Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Fairness for Patient Medications Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Fairness for Patient Medications Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Health Care Price Transparency Act of 2023
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Pharmacy Benefit Manager Reform Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
Pharmacy Benefit Manager Reform Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Pharmacy Benefit Manager Reform Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Protecting Patient Access to Cancer and Complex Therapies Act of 2023
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Supporting Medicare Providers Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Supporting Medicare Providers Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.
Supporting Medicare Providers Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Lower Costs, More Cures Act of 2021
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs.
Lower Costs, More Cures Act of 2021
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs; Medicare Administrative Contractor coding issues (non-legislative).
Elijah E. Cummings Lower Drug Costs Now Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs.
Elijah E. Cummings Lower Drug Costs Now Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs; Medicare Administrative Contractor coding issues (non-legislative).
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs; Medicare Administrative Contractor coding issues (non-legislative).
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs.
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Supporting Medicare Providers Act of 2021
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs.
Supporting Medicare Providers Act of 2021
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs; Medicare Administrative Contractor coding issues (non-legislative).
Supporting Medicare Providers Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Supporting Medicare Providers Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs; Medicare Administrative Contractor coding issues (non-legislative).
Elijah E. Cummings Lower Drug Costs Now Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement of Part B drugs in clinic setting; H. Rept. 117-130; H.R. 3.
Elijah E. Cummings Lower Drug Costs Now Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting.
Elijah E. Cummings Lower Drug Costs Now Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
Access and appropriate reimbursement for Part B drugs in clinic setting; H. Rept. 117-130; H.R. 3.
Inflation Reduction Act of 2022
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting.
Supporting Medicare Providers Act of 2021
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting.
Protecting Medicare and American Farmers from Sequester Cuts Act
Client: INFUSION PROVIDERS ALLIANCE · Firm: INFUSION PROVIDERS ALLIANCE
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2024 · fourth_quarter · Q4
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2024 · third_quarter · Q3
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging.
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Access to Alzheimer's Disease therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2024 · second_quarter · Q2
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to downcoding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to white bagging. Access to Alzheimer's Disease therapies. Issues related to virtual supervision of infusion drugs. Advocating for access to biosimilars. Access to Alzheimer's Disease therapies.
Issues related to the Change Healthcare cyber-attack.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2024 · first_quarter · Q1
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
None
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2023 · fourth_quarter · Q4
Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act. of2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act. Issues related to White Bagging. Access to Alzheimer's Disease therapies.
None
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2023 · third_quarter · Q3
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative); HR 5391, Protecting Patient Access to Cancer and Complex Therapies Act.
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act; The Lower Costs, More Transparency Act; The Stop Drug Shortages Act; H.R. 4822; Health Care Price Transparency Act of 2023; The Patient Act; Improving Seniors Timely Access to Care Act; The Cutting Copays Act; The Modernizing and Ensuring PBM Accountability Act; The Transparency in Billing Act.
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2023 · second_quarter · Q2
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act; H.R. 3284, the Providers and Payers COMPETE Act; H.R. 3237, requiring each off-campus outpatient department of a provider to include a unique identifier; H.R. 3285, the Fairness for Patient Medications Act; H.R. 3262, to increase transparency of certain health-related ownership information; S. 1214, the RARE Act.
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2023 · first_quarter · Q1
H.R. 2691, the Transparent PRICE Act; S 652/HR 2630, Safe Step Act; S 1375/HR 830, HELP Copays Act; H.R. 2679, the PBM Accountability Act; S. 1339, Pharmacy Benefit Manager Reform Act
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; HR 2474, the Strengthening Medicare for Patients and Providers Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2022 · fourth_quarter · Q4
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2022 · third_quarter · Q3
Access and appropriate reimbursement of Part B drugs in clinic setting and provisions included in Title I-Subtitle B of P.L. 117-169/H.R. 5376 -Inflation Reduction Act of 2022; H.R.8800 - Supporting Medicare Providers Act of 2022; H.R. 5376, the Build Back Better Act; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; Medicare Administrative Contractor coding issues (non-legislative).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2022 · second_quarter · Q2
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs; Medicare Administrative Contractor coding issues (non-legislative).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2022 · first_quarter · Q1
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 19, The Lower Cost, More Cures Act of 2021; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting; support for site neutral payment policies; access to Alzheimer's Disease therapies; appropriate reimbursement of Medicare Part B drugs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2021 · fourth_quarter · Q4
H.R. 5376, the Build Back Better Act; H.R. 6020, Supporting Medicare Providers Act of 2021; S. 610, Protecting Medicare and American Farmers from Sequester Cuts; Supporting Health Care Providers During the COVID-19 Pandemic Act; H. Rept. 117-130; H.R. 3; Access and appropriate reimbursement for Part B drugs in clinic setting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2021 · third_quarter · Q3
Access and appropriate reimbursement for Part B drugs in clinic setting; H. Rept. 117-130; H.R. 3.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFUSION PROVIDERS ALLIANCE via INFUSION PROVIDERS ALLIANCE
2021 · third_quarter · RR
Access and appropriate reimbursement of Part B drugs in clinic setting; H. Rept. 117-130; H.R. 3.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE